K.H. Lee
Impact in
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Treatments and Mutations 43
- Lung Cancer Diagnosis and Treatment 8
- Gastric Cancer Management and Outcomes 2
- Oncology 17
- Cancer Immunotherapy and Biomarkers 17
- Co-authors
- D.-W. Kim (6 shared papers)K. Park (8 shared papers)Byoung Chul Cho (21 shared papers)Luis G Paz-Ares (10 shared papers)Kenneth John O'Byrne (8 shared papers)James Chih‐Hsin Yang (10 shared papers)Tony S.K. Mok (7 shared papers)L. Zhang (4 shared papers)
- Journals
- Annals of Oncology (43 papers)Journal of Thoracic Oncology (9 papers)ESMO Open (2 papers)European Journal of Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- South KoreaUnited StatesSpain
In The Last Decade
K.H. Lee
57 papers receiving 1.4k citations
K.H. Lee's Hit Papers
Peers
Comparison fields: 5 of 50
- Pulmonary and Respiratory Medicine 1k
- Oncology 344
- Cancer Research 41
- Radiology, Nuclear Medicine and Imaging 23
- Pharmacology 10
Countries citing papers authored by K.H. Lee
This map shows the geographic impact of K.H. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.H. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.H. Lee more than expected).
Fields of papers citing papers by K.H. Lee
This network shows the impact of papers produced by K.H. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.H. Lee. The network helps show where K.H. Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside K.H. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial Hit paper breakdown → | 2017 | 439 |
| 2 | 2021 | 153 | |
| 3 | 2020 | 148 | |
| 4 | 2018 | 85 | |
| 5 | 2024 | 57 | |
| 6 | 2019 | 56 | |
| 7 | 2015 | 41 | |
| 8 | 2020 | 38 | |
| 9 | 2016 | 37 | |
| 10 | 2021 | 29 | |
| 11 | 2017 | 28 | |
| 12 | 2017 | 25 | |
| 13 | 2019 | 24 | |
| 14 | 2021 | 23 | |
| 15 | 2022 | 19 | |
| 16 | 2014 | 16 | |
| 17 | 2022 | 16 | |
| 18 | 2018 | 15 | |
| 19 | 2019 | 14 | |
| 20 | 2014 | 13 |
About K.H. Lee
K.H. Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hepatology, Molecular Biology and Nuclear Energy and Engineering, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (43 papers), Cancer Immunotherapy and Biomarkers (17 papers), Lung Cancer Diagnosis and Treatment (8 papers), Gastric Cancer Management and Outcomes (2 papers), Ginseng Biological Effects and Applications (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (1k citations), Oncology (344 citations), Cancer Research (41 citations), Radiology, Nuclear Medicine and Imaging (23 citations) and Pharmacology (10 citations). K.H. Lee has collaborated with scholars based in South Korea, United States and Spain. Frequent co-authors include D.-W. Kim, K. Park, Byoung Chul Cho, Luis G Paz-Ares, Kenneth John O'Byrne, James Chih‐Hsin Yang, Tony S.K. Mok, L. Zhang, Karl Gustav Kölbeck and Scott Andrew Laurie. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, ESMO Open, European Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.